QM Dental Group’s subsidiary Acumen Diagnostics was awarded a tender for the provision of Covid-19 swab and testing services. We expect QM to potentially be able to conduct an additional c.900 daily tests across phase 1 sites, as highlighted in the tender. Reiterate Add with an unchanged TP of S$0.97, pegged at 20x FY22F P/E. Potential catalysts include higher-than-expected number of tests performed.
- 1 Macro Analysis/Global G7 reiterates support for SDR allocation and seeks to boost its impact
- 2 Strategy Note/Global G7's 'Build Back Better World' is not an answer to China's Belt and Road
- 3 Strategy Note/Vietnam Vietnam: The best emerging market is still spoilt by foreign ownership limits
- 4 Macro Analysis/Pakistan Pakistan's FY22 Federal Budget – Serious push on growth
- 5 Strategy Note/Global Egypt's military spend is not securing the Nile in its dispute with Ethiopia
This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...